Single-center experience of efficacy and safety of atrioventricular node ablation after left bundle branch area pacing for the management of atrial fibrillation.
Atrial fibrillation
Atrioventricular node ablation
Heart failure
Left bundle branch area pacing
Left ventricular dyssynchrony
Physiologic pacing
Journal
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966
Informations de publication
Date de publication:
24 Jun 2024
24 Jun 2024
Historique:
received:
17
03
2024
accepted:
30
05
2024
medline:
24
6
2024
pubmed:
24
6
2024
entrez:
24
6
2024
Statut:
aheadofprint
Résumé
Atrioventricular node ablation (AVNA) with permanent pacing is an effective treatment of symptomatic atrial fibrillation (AF). Left bundle branch area pacing (LBBAP) prevents cardiac dyssynchrony associated with right ventricular pacing and could prevent worsening of heart failure (HF). In this retrospective monocentric study, all patients who received AVNA procedure with LBBAP were consecutively included. AVNA procedure data, electrical and echocardiographic parameters at 6 months, and clinical outcomes at 1 year were studied and compared to a matched cohort of patients who received AVNA procedure with conventional pacing between 2010 and 2023. Seventy-five AVNA procedures associated with LBBAP were studied. AVNA in this context was feasible, with a success rate of 98.7% at first ablation, and safe without any complications. There was no threshold rise at follow-up. At 1 year, 6 (8%) patients were hospitalized for HF and 2 (2.7%) were deceased. Patients had a significant improvement in NYHA class and left ventricular ejection fraction (LVEF) (P ≤ 0.0001). When compared to a matched cohort of patients with AVNA and conventional pacing, AVNA data and pacing complications rates were similar. Patients with LBBAP had a better improvement of LVEF (+5.27 ± 9.62% vs. -0.48 ± 14%, P = 0.01), and a lower 1-year rate of composite outcome of hospitalization for HF or death (HR 0.39, 95% CI: 0.16-0.95, P = 0.037), significant on survival analysis (log-rank P-value = 0.03). AVNA with LBBAP in patients with symptomatic AF is feasible, safe, and efficient. Hospitalization for HF or death rate was significantly lower and LVEF improvement was greater.
Sections du résumé
BACKGROUND
BACKGROUND
Atrioventricular node ablation (AVNA) with permanent pacing is an effective treatment of symptomatic atrial fibrillation (AF). Left bundle branch area pacing (LBBAP) prevents cardiac dyssynchrony associated with right ventricular pacing and could prevent worsening of heart failure (HF).
METHODS
METHODS
In this retrospective monocentric study, all patients who received AVNA procedure with LBBAP were consecutively included. AVNA procedure data, electrical and echocardiographic parameters at 6 months, and clinical outcomes at 1 year were studied and compared to a matched cohort of patients who received AVNA procedure with conventional pacing between 2010 and 2023.
RESULTS
RESULTS
Seventy-five AVNA procedures associated with LBBAP were studied. AVNA in this context was feasible, with a success rate of 98.7% at first ablation, and safe without any complications. There was no threshold rise at follow-up. At 1 year, 6 (8%) patients were hospitalized for HF and 2 (2.7%) were deceased. Patients had a significant improvement in NYHA class and left ventricular ejection fraction (LVEF) (P ≤ 0.0001). When compared to a matched cohort of patients with AVNA and conventional pacing, AVNA data and pacing complications rates were similar. Patients with LBBAP had a better improvement of LVEF (+5.27 ± 9.62% vs. -0.48 ± 14%, P = 0.01), and a lower 1-year rate of composite outcome of hospitalization for HF or death (HR 0.39, 95% CI: 0.16-0.95, P = 0.037), significant on survival analysis (log-rank P-value = 0.03).
CONCLUSION
CONCLUSIONS
AVNA with LBBAP in patients with symptomatic AF is feasible, safe, and efficient. Hospitalization for HF or death rate was significantly lower and LVEF improvement was greater.
Identifiants
pubmed: 38913133
doi: 10.1007/s10840-024-01847-2
pii: 10.1007/s10840-024-01847-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–528.
Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120(9):1501–17.
doi: 10.1161/CIRCRESAHA.117.309732
pubmed: 28450367
pmcid: 5500874
Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383(14):1305–16.
doi: 10.1056/NEJMoa2019422
pubmed: 32865375
Garcia B, Clementy N, Benhenda N, Pierre B, Babuty D, Olshansky B et al. Mortality after atrioventricular nodal radiofrequency catheter ablation with permanent ventricular pacing in atrial fibrillation: outcomes from a controlled nonrandomized study. Circ: Arrhythmia and Electrophysiology. 2016;9(7):e003993.
Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, Bongiorni MG, et al. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Circulation. 1997;21(8):2617–24.
Brignole M, Pentimalli F, Palmisano P, Landolina M, Quartieri F, Occhetta E et al. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart J. 2021;42(46):4731–9.
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373–498.
doi: 10.1093/eurheartj/ehaa612
pubmed: 32860505
Tops LF, Schalij MJ, Holman ER, van Erven L, van der Wall EE, Bax JJ. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. J Am Coll Cardiol. 2006;48(8):1642–8.
doi: 10.1016/j.jacc.2006.05.072
pubmed: 17045901
Chung MK, Patton KK, Lau CP, Dal Forno ARJ, Al-Khatib SM, Arora V, et al. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure. Heart Rhythm. 2023;20(9):e17–91.
doi: 10.1016/j.hrthm.2023.03.1538
pubmed: 37283271
pmcid: 11062890
Kiehl EL, Makki T, Kumar R, Gumber D, Kwon DH, Rickard JW, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm. 2016;13(12):2272–8.
doi: 10.1016/j.hrthm.2016.09.027
pubmed: 27855853
Yu CM, Chan JYS, Zhang Q, Omar R, Yip GWK, Hussin A, et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. New Engl J Med. 2009;361(22):2123–34.
doi: 10.1056/NEJMoa0907555
pubmed: 19915220
Vijayaraman P, Naperkowski A, Subzposh FA, Abdelrahman M, Sharma PS, Oren JW, et al. Permanent his-bundle pacing: long-term lead performance and clinical outcomes. Heart Rhythm. 2018;15(5):696–702.
doi: 10.1016/j.hrthm.2017.12.022
pubmed: 29274474
Vijayaraman P, Herweg B, Dandamudi G, Mittal S, Bhatt AG, Marcantoni L, et al. Outcomes of his-bundle pacing upgrade after long-term right ventricular pacing and/or pacing-induced cardiomyopathy: insights into disease progression. Heart Rhythm. 2019;16(10):1554–61.
doi: 10.1016/j.hrthm.2019.03.026
pubmed: 30930330
Burri H, Jastrzebski M, Cano Ó, Čurila K, de Pooter J, Huang W, et al. EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and latin American Heart Rhythm Society (LAHRS). EP Europace. 2023;25(4):1208–36.
doi: 10.1093/europace/euad043
Padala SK, Ellenbogen KA. Left bundle branch pacing is the best approach to physiological pacing. Heart Rhythm. 2020;1(1):59–67.
doi: 10.1016/j.hroo.2020.03.002
Huang W, Su L, Wu S, Xu L, Xiao F, Zhou X et al. A novel pacing strategy with low and stable output: pacing the left bundle branch immediately beyond the conduction block. Canadian Journal of Cardiology. 2017;33(12):1736.e1-1736.e3.
Jastrzębski M, Kiełbasa G, Cano O, Curila K, Heckman L, De Pooter J, et al. Left bundle branch area pacing outcomes: the multicentre European MELOS study. Eur Heart J. 2022;21(40):4161–73.
Wang Y, Zhu H, Hou X, Wang Z, Zou F, Qian Z, et al. Randomized trial of left bundle branch vs biventricular pacing for cardiac resynchronization therapy. J Am Coll Cardiol. 2022;80(13):1205–16.
doi: 10.1016/j.jacc.2022.07.019
pubmed: 36137670
Huang W, Wu S, Vijayaraman P, Su L, Chen X, Cai B et al. Cardiac resynchronization therapy in patients with nonischemic cardiomyopathy using left bundle branch pacing. JACC: Clinical Electrophysiology. 2020;6(7):849–58.
Huang W, Chen X, Su L, Wu S, Xia X, Vijayaraman P. A beginner’s guide to permanent left bundle branch pacing. Heart Rhythm. 2019;16(12):1791–6.
doi: 10.1016/j.hrthm.2019.06.016
pubmed: 31233818
Jastrzębski M, Burri H, Kiełbasa G, Curila K, Moskal P, Bednarek A, et al. The V6-V1 interpeak interval: a novel criterion for the diagnosis of left bundle branch capture. EP Europace. 2022;24(1):40–7.
doi: 10.1093/europace/euab164
Wu S, Chen X, Wang S, Xu L, Xiao F, Huang Z et al. sept. Evaluation of the criteria to distinguish left bundle branch pacing from left ventricular septal pacing. JACC: Clinical Electrophysiology. 2021;7(9):1166–77.
Jastrzębski M. ECG and pacing criteria for differentiating conduction system pacing from myocardial pacing. Arrhythm Electrophysiol Rev. 2021;10(3):172–80.
doi: 10.15420/aer.2021.26
pubmed: 34777822
pmcid: 8576513
Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–72.
doi: 10.1378/chest.09-1584
pubmed: 19762550
Pillai A, Kolominsky J, Koneru JN, Kron J, Shepard RK, Kalahasty G, et al. Atrioventricular junction ablation in patients with conduction system pacing leads: a comparison of his-bundle vs left bundle branch area pacing leads. Heart Rhythm. 2022;19(7):1116–23.
doi: 10.1016/j.hrthm.2022.03.1222
pubmed: 35351624
Vijayaraman P, Mathew AJ, Naperkowski A, Young W, Pokharel P, Batul SA, et al. Conduction system pacing versus conventional pacing in patients undergoing atrioventricular node ablation: nonrandomized, on-treatment comparison. Heart Rhythm. 2022;3(4):368–76.
doi: 10.1016/j.hroo.2022.04.005
Landolina M, Gasparini M, Lunati M, Iacopino S, Boriani G, Bonanno C et al. Long-term complications related to biventricular defibrillator implantation. Circulation. 2011;123(22):2526–35.
Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophys. 2005;16(11):1160–5.
doi: 10.1111/j.1540-8167.2005.50062.x
Orlov MV, Gardin JM, Slawsky M, Bess RL, Cohen G, Bailey W, et al. Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation. Am Heart J. 2010;159(2):264–70.
doi: 10.1016/j.ahj.2009.11.012
pubmed: 20152225
Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;14(35):3427–520.
Fang F, Sanderson JE, Yu C. man. Should all patients with heart block receive biventricular pacing? Circulation: Arrhythmia and Electrophysiology. 2015;8(3):722–9.
van Rees JB, de Bie MK, Thijssen J, Borleffs CJW, Schalij MJ, van Erven L. Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. Journal of the American College of Cardiology. 2011;58(10):995–1000.
Kirkfeldt RE, Johansen JB, Nohr EA, Moller M, Arnsbo P, Nielsen JC. Risk factors for lead complications in cardiac pacing: a population-based cohort study of 28,860 Danish patients. Heart Rhythm. 2011;8(10):1622–8.
doi: 10.1016/j.hrthm.2011.04.014
pubmed: 21699827
Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA. Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med. 2011;154(6):401–12.
Rijal S, Wolfe J, Rattan R, Durrani A, Althouse AD, Marroquin OC, et al. Lead related complications in quadripolar versus bipolar left ventricular leads. Indian Pacing Electrophysiol J. 2016;17(1):3–7.
doi: 10.1016/j.ipej.2016.10.008
pubmed: 28401860
pmcid: 5357860
Biffi M, Moschini C, Bertini M, Saporito D, Ziacchi M, Diemberger I, et al. Phrenic stimulation: a challenge for cardiac resynchronization therapy. Circ Arrhythm Electrophysiol. 2009;2(4):402–10.
doi: 10.1161/CIRCEP.108.836254
pubmed: 19808496
Chung ES, St John Sutton MG, Mealing S, Sidhu MK, Padhiar A, Tsintzos SI, et al. Economic value and cost-effectiveness of biventricular versus right ventricular pacing: results from the BLOCK-HF study. J Med Econ. 2019;22(10):1088–95.
doi: 10.1080/13696998.2019.1652184
pubmed: 31464176
Bednarek A, Kiełbasa G, Moskal P, Ostrowska A, Bednarski A, Sondej T, et al. Left bundle branch area pacing prevents pacing induced cardiomyopathy in long-term observation. Pacing Clin Electrophysiol. 2023;46(7):629–38.
doi: 10.1111/pace.14707
pubmed: 37154051
Vijayaraman P, Herweg B, Verma A, Sharma PS, Batul SA, Ponnusamy SS, et al. Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: results from International LBBAP Collaborative Study Group. Heart Rhythm. 2022;19(8):1272–80.
doi: 10.1016/j.hrthm.2022.04.024
pubmed: 35504539
Vijayaraman P, Sharma PS, Cano Ó, Ponnusamy SS, Herweg B, Zanon F, et al. Comparison of left bundle branch area pacing and biventricular pacing in candidates for resynchronization therapy. J Am Coll Cardiol. 2023;82(3):228–41.
doi: 10.1016/j.jacc.2023.05.006
pubmed: 37220862